Guilford to Present at UBS Global Life Sciences Conference
22 September 2004 - 4:03PM
PR Newswire (US)
Guilford to Present at UBS Global Life Sciences Conference
BALTIMORE, Sept. 22 /PRNewswire-FirstCall/ -- Guilford
Pharmaceuticals Inc. (NASDAQ:GLFD) announced today that it will
present at the upcoming UBS Global Life Sciences Conference on
Tuesday, September 28, 2004 at 1:00 p.m. ET at the Grand Hyatt
Hotel in New York, NY. Guilford's Chairman, President and CEO,
Craig R. Smith, M.D., will provide an update on the Company's
business as well as new developments on products currently in the
pipeline. To access the live audio webcast or the subsequent
archived recording, log on to http://www.guilfordpharm.com/. The
link for the webcast is located under the Investor Relations
section of the website under 'Conferences.' Please connect to the
website several minutes prior to the start of the conference call
to ensure adequate time for any software download that may be
necessary. About Guilford Guilford Pharmaceuticals Inc. is a
pharmaceutical company engaged in the research, development and
commercialization of proprietary drugs that target the hospital and
neurology markets. Presently, Guilford markets two commercial
products, GLIADEL(R) Wafer (polifeprosan 20 with carmustine
implant), for the treatment of brain cancer, and AGGRASTAT(R)
Injection (tirofiban hydrochloride), a glycoprotein GP IIb/IIIa
receptor antagonist, for the treatment of acute coronary syndrome
(ACS). Guilford's product pipeline includes AQUAVAN(R) Injection, a
novel sedative/anesthetic and drugs for treating peripheral nerve
injury. For full prescribing information, please visit
http://www.guilfordpharm.com/ under Products / Marketed Products.
CONTACT: Stacey Jurchison, Director, Corporate Communications,
Guilford Pharmaceuticals, (410) 631-5022; .
http://www.guilfordpharm.com/. DATASOURCE: Guilford Pharmaceuticals
Inc. CONTACT: Stacey Jurchison, Director, Corporate Communications,
Guilford Pharmaceuticals, +1-410-631-5022, Web site:
http://www.guilfordpharm.com/ Company News On-Call:
http://www.prnewswire.com/comp/112882.html
Copyright
Guilford (NASDAQ:GLFD)
Historical Stock Chart
Von Nov 2024 bis Dez 2024
Guilford (NASDAQ:GLFD)
Historical Stock Chart
Von Dez 2023 bis Dez 2024
Echtzeit-Nachrichten über Guilford Pharmaceuticals (MM) (NASDAQ): 0 Nachrichtenartikel
Weitere Guilford Pharmaceuticals (MM) News-Artikel